Earnings · China A-shares

Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A (688266) earnings

Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A published its Q3 report on 2026-10-30: net profit +783.25% year on year, +604.75% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved +11.70% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-30
Period end
2026-09-30
Net profit YoY
+783.25%
Excl. one-offs YoY
+604.75%
Net profit QoQ
-123.58%
Result
Great
Quality score
82
Quality
Sound
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+4.36%—
3 days+11.70%—
7 days+9.82%—
14 days-5.25%—

Report history

Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 4 of 7 reports (average +2.83%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-31¥638.27M+783.25%+604.75%+158.91%2.4145.60%+11.70%——
2026 interim report2026-08-01¥640.01M+979.09%+700.66%+220.88%2.4245.70%-9.62%-12.64%-11.24%
2026 Q1 report2026-04-29¥632.61M+2338.37%+1362.40%+440.07%2.3945.29%+6.64%-6.58%-7.52%
2025 annual report2026-03-28-¥162.95M-18.22%-15.60%+52.07%-0.62-13.96%+3.39%-0.09%-9.45%
2025 Q3 report2025-10-31-¥93.42M+4.58%-15.42%+54.49%-0.35-7.78%+15.92%+21.15%+25.84%
2025 interim report2025-08-23-¥72.80M-9.42%-41.83%+56.07%-0.28-5.98%-6.05%-7.15%-12.02%
2025 Q1 report2025-04-19-¥28.26M+28.45%-17.83%+54.87%-0.11-2.28%-2.14%+14.54%+11.59%
2024 annual report2025-04-19-¥137.83M+50.52%+50.92%+37.91%-0.52-9.42%-2.14%+14.54%+11.59%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 688266

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.